Related Experiment Video
Updated: Mar 16, 2026

Three-Dimensional 3D Tumor Spheroid Invasion Assay
Published on: May 1, 2015
Regulator of G protein signaling 20 enhances cancer cell aggregation, migration, invasion and adhesion
Lei Yang1, Maggie M K Lee1, Manton M H Leung1
1Division of Life Science, Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Abstract:
Several RGS (regulator of G protein signaling) proteins are known to be upregulated in a variety of tumors but their roles in modulating tumorigenesis remain undefined. Since the expression of RGS20 is elevated in metastatic melanoma and breast tumors, we examined the effects of RGS20 overexpression and knockdown on the cell mobility and adhesive properties of different human cancer cell lines, including cervical cancer HeLa, breast adenocarcinoma MDA-MB-231, and non-small cell lung carcinoma H1299 and A549 cells. Expression of RGS20 enhanced cell aggregation, migration, invasion and adhesion as determined by hanging drop aggregation, wound healing, transwell chamber migration and invasion assays. Conversely, shRNA-mediated knockdown of endogenous RGS20 impaired these responses. In addition, RGS20 elevated the expression of vimentin (a mesenchymal cell marker) but down-regulated the expression of E-cadherin, two indicators commonly associated with metastasis. These results suggest that the expression of RGS20 may promote metastasis of tumor cells.
Insights
Regulator of G protein signaling 20 (RGS20) protein promotes tumor cell metastasis. Overexpression of RGS20 enhances cancer cell migration and adhesion, while its knockdown impairs these processes, suggesting RGS20 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Regulator of G protein signaling (RGS) proteins are implicated in various cancers.
- The specific role of RGS20 in tumorigenesis is largely undefined.
- RGS20 expression is elevated in metastatic melanoma and breast tumors.
Purpose of the Study:
- To investigate the functional role of RGS20 in cancer cell mobility and adhesion.
- To determine the effect of RGS20 modulation on key metastatic indicators.
Main Methods:
- Overexpression and shRNA-mediated knockdown of RGS20 in human cancer cell lines (HeLa, MDA-MB-231, H1299, A549).
- Assays included hanging drop aggregation, wound healing, transwell migration, and invasion assays.
- Analysis of vimentin and E-cadherin expression levels.
Main Results:
- RGS20 overexpression significantly enhanced cell aggregation, migration, invasion, and adhesion.
- Knockdown of RGS20 impaired these metastatic properties.
- RGS20 elevated vimentin expression and decreased E-cadherin expression, markers associated with epithelial-mesenchymal transition and metastasis.
Conclusions:
- RGS20 expression promotes tumor cell metastasis by enhancing cell mobility and adhesion.
- RGS20 may serve as a potential biomarker or therapeutic target for metastatic cancers.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Selectins
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Chemotaxis and Direction of Cell Migration

